Author

Cathy Fleming

Observed names: C. Fleming, Cathy E. Fleming

Observed institutions: University College Dublin, St. Luke's Hospital

ORCID: 0000-0003-3517-6738

Observed ORCID: 0000-0003-3517-6738

OpenAlex ID: A5048319130

Emergency First Presentation of Colorectal Cancer Predicts Significantly Poorer Outcomes: A Review of 356 Consecutive Irish Patients

2009 · Gary Bass, Cathy Fleming, et al. · Diseases of the Colon & Rectum · 91

Normal tissue considerations and dose–volume constraints in the moderately hypofractionated treatment of non-small cell lung cancer

2016 · Cathy Fleming, Daniel N. Cagney, et al. · Radiotherapy and Oncology · 29

A Method for the Prediction of Late Organ-at-Risk Toxicity After Radiotherapy of the Prostate Using Equivalent Uniform Dose

2010 · Cathy Fleming, Colin Kelly, et al. · International Journal of Radiation Oncology*Biology*Physics · 15

A Phase II Toxicity End Point Trial (ICORG 99-09) of Accelerated Dose-escalated Hypofractionated Radiation in Non-small Cell Lung Cancer

2017 · D.N. Cagney, P.G. Thirion, et al. · Clinical Oncology · 11

The influence of Acuros XB on dose volume histogram metrics and tumour control probability modelling in locally advanced non-small cell lung cancer

2021 · Cathy Fleming, Serena O'Keeffe, et al. · Physica Medica · 4

The potential for increased tumor control probability in non–small cell lung cancer with a hypofractionated integrated boost to the gross tumor volume

2017 · Cathy Fleming, Serena O'Keeffe, et al. · Medical dosimetry · 2

2964 A TOPAS Monte-Carlo model of standard and FLASH-enabled Elekta linacs for in vitro dose verification and prediction

2026 · Oran McElligott, Cathy Fleming, et al. · Radiotherapy and Oncology

4706 Evaluation of the effect of rotations on coverage of nodal boosts in gynae SIB patients

2026 · Robert Smyth, Cathy Fleming, et al. · Radiotherapy and Oncology

Evaluating dose coverage and conformity in stereotactic ablative body radiotherapy (SABR) plans

2024 · Serena O'Keeffe, Cathy Fleming, et al. · Physica Medica

A strategy to reduce fraction number in peripheral lung stereotactic ablative body radiotherapy

2023 · Serena O'Keeffe, Martin J. Higgins, et al. · Physics and Imaging in Radiation Oncology

Quantification of Incidental Clinical Target Volume Coverage in Linear Accelerator Based Lung Sabr

2022 · Ms Serena O’keeffe, Martin Higgins, et al. · Physica Medica

Dose volume histogram metrics and tumour control probability modelling in locally advanced non-small-cell lung cancer: average intensity dataset versus individual four-dimensional CT phases

2020 · Cathy Fleming, Ronan McDermott, et al. · Journal of Radiotherapy in Practice

Field in field breast planning in SLRON

2014 · Cathy Fleming, Christina Skourou, et al. · Physica Medica

90 Retrospective audit of radically treated non-small cell lung cancer (NSCLC) patients at the St James's Institute of Oncology (SJIO), Leeds Teaching Hospital NHS Trust (LTHT)

2012 · K. Franks, A. Rees, et al. · Lung Cancer

Roedl JB et al., Adenocarcinomas of the esophagus: response to chemoradiotherapy is associated with decrease of metabolic tumor volume as measured on PET–CT comparison to histopathologic and clinical response evaluation, Radiother Oncol 2008; 89: 278–86.

2009 · Cathy E. Fleming, Gary Bass, et al. · Radiotherapy and Oncology

4036 POSTER Natural history of long-term radiation induced-proctopathy following localised high-dose 3-dimensional radiation therapy for prostate cancer

2007 · P. Thirion, D. Fitzpatrick, et al. · European Journal of Cancer Supplements

Works count: 16

Citation count: 152

H-index: 4

I10-index: 4